The correlation between IL-20 and the Th2 immune response in human asthma.

Backround: Interleukin-20 (IL-20) belongs to the IL-10 family, which has been shown to be crucial in immune responses, regulation of inflammatory responses, hemopoiesis, and epidermal cell and keratinocyte differentiation. However, the role of IL-20 in asthma remains unclear. Here, our aim is to evaluate the correlation between IL-20 and the Th2 immune response in human.

Interleukin-20 promotes airway remodeling in asthma.

Previous studies have demonstrated that interleukin-20 (IL-20) is a pro-inflammatory cytokine, and it has been implicated in psoriasis, lupus nephritis, rheumatoid arthritis, atherosclerosis, and ulcerative colitis. Little is known about the effects of IL-20 in airway remodeling in asthma. The aim of our study was to demonstrate the function of IL-20 in airway remodeling in asthma.

[Effect of XPA expression on the chemotherapy sensitivity of A549/DDP cells].

Aim: To investigate the influence on platinum-based chemotherapy sensitivity by silencing xeroderma pigmentosum group A (XPA) gene expression in non-small cell lung cancer (NSCLC) drug resistance cell lines (A549/DDP).

Methods: We detected the expression of XPA in lung normal and tumor tissues by immunohistochemistry, quantitative real-time PCR (qPCR) and Western blotting. We silenced XPA expression in A549/DDP cells by XPA-shRNA transfection, and detected the expression of XPA by qPCR and Western blotting.

Thymic stromal lymphopoietin promotes lung inflammation through activation of dendritic cells.

Asthma is an epithelial disorder in which T helper 2 (Th2)-type inflammation has a prominent role. Recent studies indicated that a cytokine, thymic stromal lymphopoietin (TSLP), is essential for the development of antigen-induced asthma. The authors used ovalbumin (OVA) sensitization and challenge to induce a murine asthmatic model.